{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:58:34Z","timestamp":1793059114022,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00259-021-05299-y","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T01:02:21Z","timestamp":1615078941000},"page":"3847-3858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Manon","family":"Bordonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad B.","family":"Chawki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Kas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Tyvaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2194-0328","authenticated-orcid":false,"given":"Antoine","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"issue":"4","key":"5299_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"issue":"1","key":"5299_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1743-422X-5-134","volume":"5","author":"F Jmor","year":"2008","unstructured":"Jmor F, Emsley HC, Fischer M, Solomon T, Lewthwaite P. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol J. 2008;5(1):134. https:\/\/doi.org\/10.1186\/1743-422X-5-134.","journal-title":"Virol J"},{"issue":"2","key":"5299_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"issue":"12","key":"5299_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835\u201344. https:\/\/doi.org\/10.1016\/S1473-3099(10)70222-X.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"5299_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1086\/648419","volume":"49","author":"A Mailles","year":"2009","unstructured":"Mailles A, Stahl J. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009;49(12):1838\u201347. https:\/\/doi.org\/10.1086\/648419.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5299_CR6","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1097\/RLU.0000000000001076","volume":"41","author":"MDP C\u00f3zar Santiago","year":"2016","unstructured":"C\u00f3zar Santiago MDP, Sanchez Jurado R, Sanz Llorens R, Aguilar Barrios JE, Ferrer Rebolleda J. Limbic encephalitis diagnosed With 18F-FDG PET\/CT. Clin Nucl Med. 2016;41(2):e101\u20133. https:\/\/doi.org\/10.1097\/RLU.0000000000001076.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"5299_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77(2):179\u201389. https:\/\/doi.org\/10.1212\/WNL.0b013e318224afde.","journal-title":"Neurology."},{"issue":"3","key":"5299_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12254-012-0034-z","volume":"5","author":"MR Rosenfeld","year":"2012","unstructured":"Rosenfeld MR, Dalmau J. Paraneoplastic neurologic disorders: a brief overview. Memo. 2012;5(3):197\u2013200. https:\/\/doi.org\/10.1007\/s12254-012-0034-z.","journal-title":"Memo."},{"issue":"2","key":"5299_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1941874412453339","volume":"3","author":"A McKeon","year":"2013","unstructured":"McKeon A. Paraneoplastic and other autoimmune disorders of the central nervous system. Neurohospitalist. 2013;3(2):53\u201364. https:\/\/doi.org\/10.1177\/1941874412453339.","journal-title":"Neurohospitalist."},{"issue":"1","key":"5299_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/0004-282X20170176","volume":"76","author":"LA Dutra","year":"2018","unstructured":"Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr. 2018;76(1):41\u20139. https:\/\/doi.org\/10.1590\/0004-282X20170176.","journal-title":"Arq Neuropsiquiatr"},{"issue":"16","key":"5299_CR11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543\u201354. https:\/\/doi.org\/10.1056\/NEJMra023009.","journal-title":"N Engl J Med"},{"issue":"3","key":"5299_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","volume":"27","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol. 2014;27(3):361\u20138. https:\/\/doi.org\/10.1097\/WCO.0000000000000087.","journal-title":"Curr Opin Neurol"},{"key":"5299_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J, Pr\u00fcss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis--relevance for clinical practice and hippocampal function. Neuroscience. 2015;309:68\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.037.","journal-title":"Neuroscience."},{"key":"5299_CR14","doi-asserted-by":"publisher","unstructured":"Diaz-Arias LA, Pardo CA, Probasco JC. Autoimmune encephalitis in the intensive care unit. In: Nelson SE, Nyquist PA, eds. Neurointensive Care Unit. Current Clinical Neurology. Springer International Publishing; 2020:249\u2013263. https:\/\/doi.org\/10.1007\/978-3-030-36548-6_17.","DOI":"10.1007\/978-3-030-36548-6_17"},{"key":"5299_CR15","doi-asserted-by":"publisher","unstructured":"Guerin J, Watson RE, Carr CM, Liebo GB, Kotsenas AL. Autoimmune epilepsy: findings on MRI and FDG-PET. Br J Radiol. 2019;92(1093). https:\/\/doi.org\/10.1259\/bjr.20170869.","DOI":"10.1259\/bjr.20170869"},{"key":"5299_CR16","doi-asserted-by":"publisher","unstructured":"Kyritsis AP, Markoula S, Alexiou G, et al. Diagnosis and treatment of limbic encephalitis in the cancer patient. Future Oncol Published online June 8, 2020. https:\/\/doi.org\/10.2217\/fon-2020-0080.","DOI":"10.2217\/fon-2020-0080"},{"key":"5299_CR17","doi-asserted-by":"publisher","first-page":"7506590","DOI":"10.1155\/2020\/7506590","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Xiao Z. Current progress on assessing the prognosis for anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Biomed Res Int. 2020;2020:7506590. https:\/\/doi.org\/10.1155\/2020\/7506590.","journal-title":"Biomed Res Int"},{"issue":"3","key":"5299_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","volume":"16","author":"KS Husari","year":"2019","unstructured":"Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics. 2019;16(3):685\u2013702. https:\/\/doi.org\/10.1007\/s13311-019-00750-3.","journal-title":"Neurotherapeutics."},{"key":"5299_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jocn.2018.03.026","volume":"52","author":"S Bacchi","year":"2018","unstructured":"Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D. Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci. 2018;52:54\u20139. https:\/\/doi.org\/10.1016\/j.jocn.2018.03.026.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"5299_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97(2):839\u201387. https:\/\/doi.org\/10.1152\/physrev.00010.2016.","journal-title":"Physiol Rev"},{"issue":"4","key":"5299_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.23736\/S1824-4785.17.03024-2","volume":"61","author":"J Arbizu","year":"2017","unstructured":"Arbizu J, Giuliani A, G\u00e1llego Perez-Larraya J, et al. Emerging clinical issues and multivariate analyses in PET investigations. Q J Nucl Med Mol Imaging. 2017;61(4):386\u2013404. https:\/\/doi.org\/10.23736\/S1824-4785.17.03024-2.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"8","key":"5299_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.328","volume":"3","author":"A Venkatraman","year":"2016","unstructured":"Venkatraman A, Opal P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies \u2013 a review. Ann Clin Transl Neurol. 2016;3(8):655\u201363. https:\/\/doi.org\/10.1002\/acn3.328.","journal-title":"Ann Clin Transl Neurol"},{"key":"5299_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/B978-0-444-63432-0.00026-8","volume":"133","author":"M Lim","year":"2016","unstructured":"Lim M, Gorman M. Autoimmune neurologic disorders in children. Handb Clin Neurol. 2016;133:485\u2013510. https:\/\/doi.org\/10.1016\/B978-0-444-63432-0.00026-8.","journal-title":"Handb Clin Neurol"},{"key":"5299_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jneuroim.2015.05.002","volume":"284","author":"N Quartuccio","year":"2015","unstructured":"Quartuccio N, Caobelli F, Evangelista L, et al. The role of PET\/CT in the evaluation of patients affected by limbic encephalitis: a systematic review of the literature. J Neuroimmunol. 2015;284:44\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.002.","journal-title":"J Neuroimmunol"},{"issue":"14","key":"5299_CR25","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/0961203312459104","volume":"21","author":"S-W Lee","year":"2012","unstructured":"Lee S-W, Park M, Lee S-K, Park Y-B. The efficacy of brain F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings. Lupus. 2012;21(14):1531\u20137. https:\/\/doi.org\/10.1177\/0961203312459104.","journal-title":"Lupus."},{"issue":"4","key":"5299_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396. https:\/\/doi.org\/10.1001\/jama.2017.19163.","journal-title":"JAMA."},{"issue":"8","key":"5299_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"issue":"1","key":"5299_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psym.2019.08.007","volume":"61","author":"N Kerik-Rotenberg","year":"2020","unstructured":"Kerik-Rotenberg N, Diaz-Meneses I, Hernandez-Ramirez R, et al. A metabolic brain pattern associated with anti-N-methyl-D-aspartate receptor encephalitis. Psychosomatics. 2020;61(1):39\u201348. https:\/\/doi.org\/10.1016\/j.psym.2019.08.007.","journal-title":"Psychosomatics."},{"issue":"6","key":"5299_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00259-019-04302-x","volume":"46","author":"S Turpin","year":"2019","unstructured":"Turpin S, Martineau P, Levasseur M-A, et al. 18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET\/CT) findings in children with encephalitis and comparison to conventional imaging. Eur J Nucl Med Mol Imaging. 2019;46(6):1309\u201324. https:\/\/doi.org\/10.1007\/s00259-019-04302-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5299_CR30","doi-asserted-by":"publisher","unstructured":"Schubert J, Br\u00e4mer D, Huttner HB, et al. Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm. 2018;6(1). https:\/\/doi.org\/10.1212\/NXI.0000000000000514.","DOI":"10.1212\/NXI.0000000000000514"},{"issue":"4","key":"5299_CR31","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","volume":"4","author":"JC Probasco","year":"2017","unstructured":"Probasco JC, Solnes L, Nalluri A, et al. Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e352. https:\/\/doi.org\/10.1212\/NXI.0000000000000352.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"5299_CR32","first-page":"1291","volume":"22","author":"DJ Fiorella","year":"2001","unstructured":"Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair AA. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. AJNR Am J Neuroradiol. 2001;22(7):1291\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"5299_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67(4):470\u20138. https:\/\/doi.org\/10.1002\/ana.21917.","journal-title":"Ann Neurol"},{"issue":"2","key":"5299_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neurol.2012.05.014","volume":"169","author":"J Aupy","year":"2013","unstructured":"Aupy J, Collongues N, Blanc F, Tranchant C, Hirsch E, De Seze J. Enc\u00e9phalites dysimmunitaires, donn\u00e9es cliniques, radiologiques et immunologiques. Rev Neurol. 2013;169(2):142\u201353. https:\/\/doi.org\/10.1016\/j.neurol.2012.05.014.","journal-title":"Rev Neurol"},{"issue":"11","key":"5299_CR35","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","volume":"260","author":"A Baumgartner","year":"2013","unstructured":"Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013;260(11):2744\u201353. https:\/\/doi.org\/10.1007\/s00415-013-7048-2.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"5299_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","volume":"265","author":"Y-W Shin","year":"2013","unstructured":"Shin Y-W, Lee S-T, Shin J-W, et al. VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol. 2013;265(1\u20132):75\u201381. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.10.005.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"5299_CR37","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/MNM.0000000000000163","volume":"35","author":"N Masangkay","year":"2014","unstructured":"Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 2014;35(10):1038\u201346. https:\/\/doi.org\/10.1097\/MNM.0000000000000163.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"5299_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2377-14-136","volume":"14","author":"F Wegner","year":"2014","unstructured":"Wegner F, Wilke F, Raab P, et al. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol. 2014;14(1):136. https:\/\/doi.org\/10.1186\/1471-2377-14-136.","journal-title":"BMC Neurol"},{"key":"5299_CR39","doi-asserted-by":"publisher","unstructured":"Flanagan EP, Kotsenas AL, Britton JW, et al. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015;2(6). https:\/\/doi.org\/10.1212\/NXI.0000000000000161.","DOI":"10.1212\/NXI.0000000000000161"},{"issue":"8","key":"5299_CR40","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","volume":"58","author":"LB Solnes","year":"2017","unstructured":"Solnes LB, Jones KM, Rowe SP, et al. Diagnostic value of 18 F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med. 2017;58(8):1307\u201313. https:\/\/doi.org\/10.2967\/jnumed.116.184333.","journal-title":"J Nucl Med"},{"key":"5299_CR41","doi-asserted-by":"publisher","unstructured":"Jang Y, Lee S-T, Bae J-Y, et al. LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis. J Neuroinflammation. 2018;15. https:\/\/doi.org\/10.1186\/s12974-018-1314-2.","DOI":"10.1186\/s12974-018-1314-2"},{"key":"5299_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","volume":"60","author":"C Steriade","year":"2018","unstructured":"Steriade C, Moosa ANV, Hantus S, Prayson RA, Alexopoulos A, Rae-Grant A. Electroclinical features of seizures associated with autoimmune encephalitis. Seizure. 2018;60:198\u2013204. https:\/\/doi.org\/10.1016\/j.seizure.2018.06.021.","journal-title":"Seizure."},{"issue":"2","key":"5299_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00234-017-1956-2","volume":"60","author":"M Tripathi","year":"2018","unstructured":"Tripathi M, Tripathi M, Roy SG, et al. Metabolic topography of autoimmune non-paraneoplastic encephalitis. Neuroradiology. 2018;60(2):189\u201398. https:\/\/doi.org\/10.1007\/s00234-017-1956-2.","journal-title":"Neuroradiology."},{"key":"5299_CR44","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fneur.2018.01143","volume":"9","author":"M Falip","year":"2018","unstructured":"Falip M, Rodriguez-Bel L, Casta\u00f1er S, et al. Hippocampus and insula are targets in epileptic patients with glutamic acid decarboxylase antibodies. Front Neurol. 2018;9:1143. https:\/\/doi.org\/10.3389\/fneur.2018.01143.","journal-title":"Front Neurol"},{"key":"5299_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fneur.2019.00576","volume":"10","author":"R-J Lv","year":"2019","unstructured":"Lv R-J, Pan J, Zhou G, et al. Semi-quantitative FDG-PET analysis increases the sensitivity compared with visual analysis in the diagnosis of autoimmune encephalitis. Front Neurol. 2019;10:576. https:\/\/doi.org\/10.3389\/fneur.2019.00576.","journal-title":"Front Neurol"},{"issue":"2","key":"5299_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3174\/ajnr.A5929","volume":"40","author":"T Strohm","year":"2019","unstructured":"Strohm T, Steriade C, Wu G, Hantus S, Rae-Grant A, Larvie M. FDG-PET and MRI in the evolution of new-onset refractory status Epilepticus. Am J Neuroradiol. 2019;40(2):238\u201344. https:\/\/doi.org\/10.3174\/ajnr.A5929.","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"5299_CR47","doi-asserted-by":"publisher","first-page":"e0227906","DOI":"10.1371\/journal.pone.0227906","volume":"15","author":"C Deuschl","year":"2020","unstructured":"Deuschl C, R\u00fcber T, Ernst L, et al. 18F-FDG-PET\/MRI in the diagnostic work-up of limbic encephalitis. Treglia G, ed. PLoS One. 2020;15(1):e0227906. https:\/\/doi.org\/10.1371\/journal.pone.0227906.","journal-title":"PLoS One"},{"key":"5299_CR48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fneur.2020.00418","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Shan W, Zhao X, et al. The clinical value of 18F-FDG-PET in autoimmune encephalitis associated with LGI1 antibody. Front Neurol. 2020;11:418. https:\/\/doi.org\/10.3389\/fneur.2020.00418.","journal-title":"Front Neurol"},{"issue":"8","key":"5299_CR49","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340. https:\/\/doi.org\/10.1136\/jnnp.2003.034447.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"5299_CR50","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1021\/acschemneuro.7b00319","volume":"8","author":"A Venkatesan","year":"2017","unstructured":"Venkatesan A, Adatia K. Anti-NMDA-receptor encephalitis: from bench to clinic. ACS Chem Neurosci. 2017;8(12):2586\u201395. https:\/\/doi.org\/10.1021\/acschemneuro.7b00319.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5299_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","volume":"1338","author":"F Leypoldt","year":"2015","unstructured":"Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies: autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338(1):94\u2013114. https:\/\/doi.org\/10.1111\/nyas.12553.","journal-title":"Ann N Y Acad Sci"},{"key":"5299_CR52","doi-asserted-by":"publisher","unstructured":"Najjar S, Steiner J, Najjar A, Bechter K. A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis. J Neuroinflammation. 2018;15. https:\/\/doi.org\/10.1186\/s12974-018-1067-y.","DOI":"10.1186\/s12974-018-1067-y"},{"issue":"1","key":"5299_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1021\/acschemneuro.8b00304","volume":"10","author":"EM Staley","year":"2019","unstructured":"Staley EM, Jamy R, Phan AQ, Figge DA, Pham HP. N -methyl- D -aspartate receptor antibody encephalitis: a concise review of the disorder, diagnosis, and management. ACS Chem Neurosci. 2019;10(1):132\u201342. https:\/\/doi.org\/10.1021\/acschemneuro.8b00304.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5299_CR54","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","volume":"5","author":"JC Probasco","year":"2018","unstructured":"Probasco JC, Solnes L, Nalluri A, et al. Decreased occipital lobe metabolism by FDG-PET\/CT: an anti-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm. 2018;5(1):e413. https:\/\/doi.org\/10.1212\/NXI.0000000000000413.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"5","key":"5299_CR55","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1684\/epd.2019.1094","volume":"21","author":"M Goudot","year":"2019","unstructured":"Goudot M, Frismand S, Hopes L, et al. GAD65-Ab encephalitis and subtle focal status epilepticus. Epileptic Disord. 2019;21(5):437\u201342. https:\/\/doi.org\/10.1684\/epd.2019.1094.","journal-title":"Epileptic Disord"},{"issue":"2","key":"5299_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","volume":"13","author":"S Varadkar","year":"2014","unstructured":"Varadkar S, Bien CG, Kruse CA, et al. Rasmussen\u2019s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13(2):195\u2013205. https:\/\/doi.org\/10.1016\/S1474-4422(13)70260-6.","journal-title":"Lancet Neurol"},{"issue":"1","key":"5299_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(10)70253-2.","journal-title":"Lancet Neurol"},{"issue":"10","key":"5299_CR58","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/ene.13728","volume":"25","author":"F Nobili","year":"2018","unstructured":"Nobili F, Arbizu J, Bouwman F, et al. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018;25(10):1201\u201317. https:\/\/doi.org\/10.1111\/ene.13728.","journal-title":"Eur J Neurol"},{"key":"5299_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yebeh.2018.09.043","volume":"89","author":"N Hansen","year":"2018","unstructured":"Hansen N, Widman G, Stuff S, et al. Cancer frequency detected by positron emission tomography-computed tomography in limbic encephalitis. Epilepsy Behav. 2018;89:105\u201311. https:\/\/doi.org\/10.1016\/j.yebeh.2018.09.043.","journal-title":"Epilepsy Behav"},{"key":"5299_CR60","doi-asserted-by":"publisher","unstructured":"Kampe KKW, Rotermund R, Tienken M, et al. Diagnostic value of positron emission tomography combined with computed tomography for evaluating critically ill neurological patients. Front Neurol. 2017;8. https:\/\/doi.org\/10.3389\/fneur.2017.00033.","DOI":"10.3389\/fneur.2017.00033"},{"issue":"7","key":"5299_CR61","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","volume":"83","author":"F Leypoldt","year":"2012","unstructured":"Leypoldt F, Buchert R, Kleiter I, et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83(7):681\u20136. https:\/\/doi.org\/10.1136\/jnnp-2011-301969.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5299_CR62","doi-asserted-by":"publisher","unstructured":"Verger A, Lagarde S, Maillard L, Bartolomei F, Guedj E. Brain molecular imaging in pharmacoresistant focal epilepsy: current practice and perspectives. Rev Neurol (Paris). Published online June 5, 2017. https:\/\/doi.org\/10.1016\/j.neurol.2017.05.001.","DOI":"10.1016\/j.neurol.2017.05.001"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05299-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T01:11:51Z","timestamp":1632964311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5299"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05299-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-243472\/v1","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent has been obtained for each patient for whom their FDG PET images are included in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}